• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Promimic

10.30 SEK

0.00 %

Less than 1K followers

PRO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
Compare
0.00 %
-8.04 %
-5.94 %
-39.23 %
-28.97 %
-43.09 %
-60.38 %
-
-36.74 %

Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.

Read more
Market cap
194.59M SEK
Turnover
1.13K SEK
Revenue
44.42M
EBIT %
-17.33 %
P/E
-
Dividend yield-%
-
Financial calendar
20.8
2026

Interim report Q2'26

19.11
2026

Interim report Q3'26

25.2
2027

Annual report '26